Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry-Reference-Cited by-同舟云学术

Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry

Published:2021-12 Issue: Volume:345 Page:7-13
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Cesaro Arturo,Gragnano Felice,Calabrò Paolo,Moscarella Elisabetta,Santelli Francesco,Fimiani Fabio,Patti Giuseppe,Cavallari Ilaria,Antonucci Emilia,Cirillo Plinio,Pignatelli Pasquale,Palareti Gualtiero,Pelliccia Francesco,Bossone Eduardo,Pengo Vittorio,Gresele Paolo,Marcucci Rossella,Schiavo Alessandra,Vergara Andrea,Pastori Daniele,Menichelli Danilo,Grossi Guido,Di Serafino Luigi,Taglialatela Vittorio,del Pinto Maurizio,Gugliemini Giuseppe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines: an update of the…;Levine;Circulation,2016

3. Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with ST-segment–elevation myocardial infarction;Gargiulo;Circulation,2020

4. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes;Knuuti;Eur. Heart J.,2020

5. Ticagrelor for secondary prevention of atherothrombotic events in patients with multivessel coronary disease;Bansilal;J. Am. Coll. Cardiol.,2018

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Red blood cell transfusion and mortality after transcatheter aortic valve implantation via transapical approach: A propensity-matched comparison from the TRITAVI registry;IJC Heart & Vasculature;2024-08

2. Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry;Scientific Reports;2024-06-24

3. Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease;Atherosclerosis;2024-06

4. Living with cardiomyopathy: Patients’ pathways and unmet needs;Polish Heart Journal;2024-05-31

5. Dual pathway antithrombotic treatment and risk reduction in patients with atherosclerotic cardiovascular disease: A real-world perspective;Atherosclerosis;2024-04